CV x SINS

Liana Fattore
CNR Senior Researcher
Institute of Neuroscience (IN), National Research Council (CNR)-Italy
Cittadella Universitaria di Monserrato, 09042 Monserrato (CA), Italy.
Phone:
+39 (0)70 675 4327
Fax:
+39 (0)70 675 4312
Mobile:
+39 349 1073951
E-mail address:
[email protected] – [email protected]
Website:
http://www.researchgate.net/profile/Liana_Fattore/
EDUCATION
1994
1997
2003
2005
BSc in Biology (cum laude), University of Cagliari (Italy).
BSc in Natural Sciences (cum laude), University of Cagliari (Italy).
Ph.D. in Neuroscience (cum laude), University of Cagliari (Italy).
Post-doc Course in Neuroscience, Karolinska Institute, Stockholm (Sweden).
RESEARCH & TEACHING EXPERIENCE AND POSITIONS
2000-current
2001-2002
2001-2009
2005-2007
2005-2013
2006-current
2010-current
2014
Researcher affiliated with the Centre of Excellence “Neurobiology of Addiction” (Italy).
Visiting Research Fellow, Dept. Experimental Psychology, Univ Cambridge (UK).
Researcher, CNR Institute of Neuroscience, National Research Council, Italy.
Teaching in 2nd Level Master on Drug Dependence and Alcoholism, Univ Cagliari (Italy).
Students Internship Tutoring, IN-CNR (Italy).
Neuroscience PhD Students Tutoring, University of Cagliari (Italy).
Senior Researcher, CNR Institute of Neuroscience, National Research Council, Italy.
Associate Professor National Admission (ASN, Scientific Sector: “Pharmacology”).
SCIENTIFIC HONOURS & AWARDS
1994
1995
2000
MIUR 1-year Fellowship, Specialization Course in Pharmacology, University of Cagliari
2-year Research Fellowship (ex art. 37 L.R. n. 2/94) from Regione Sardegna.
Travel Grant, Italian Society of Pharmacology (SIF), in support to the research activity at the
Dept. Experimental Psychology, University of Cambridge (UK).
2004
Poster selected by the ECNP (European College of Neuropharmacology) Workshop on
Neuropsychopharmacology for Young Scientists (Nice, France) to be included in the talks of
the “Hot topics session” at the 18th ECNP Meeting, Amsterdam (The Netherlands).
2005
Young Investigator Award, International Society for Neurochemistry and European Society
for Neurochemistry (ISN-ESN).
2006
Travel Grant, International Cannabinoid Research Society (ICRS), to attend the 2006 MiniConvention: Frontiers in Addiction Research, Atlanta (USA).
2007
Travel Grant, British Pharmacological Society (BPS), to attend the Focused Meeting/3rd
European Workshop on Cannabinoid Research, Nottingham (UK).
2008-current: Expert Evaluator, France's National Research Agency – ANR (Agence Nationale de la
Recherche).
INVITED SEMINARS, TALKS & LECTURES AT FOREIGN UNIVERITIES OR RESEARCH
INSTITUTES
2014
2014
2013
2012
2012
2011
2010
2009
2008
2006
2005
“Gender differences in substance use and abuse”, Phytochemistry Summer School, Stintino (Italy).
“Gender-dependent differences in the pharmacological effects of drug abuse”, Workshop
"Neuroplasticity in Addiction and Recovery: From Genes to Culture and Back Again", ZiF Center
for Interdisciplinary Research, Bielefeld (Germany).
“New Internet drugs”, CEITEC, Masaryk University, Brno (Czech Republic).
“Internet drugs”, Insubria International Summer School, Busto Arsizio (Italy).
“The last generation of designer drugs”, 3rd Neuromed School, Tétouan (Morocco).
“Effect of sex on cannabinoid-induced behavioural effects”, 3rd International Summer School of
Gender Medicine, Sassari (Italy).
“Gender differences in Drug Addiction”, PhD Seminar School, Biological Sciences, Sassari (Italy).
“Animal models of addiction”, 7th International Summer School of Neuroscience, Catania (Italy).
"Neurotransmitters involved in drug addiction", Groningen University (The Netherlands).
"Cannabinoid-opioid interactions in the regulation of drug-taking and drug-seeking behaviour",
University of Aberdeen (Scotland).
"The endocannabinoid system in addiction and relapse", Institut Pasteur, Paris (France).
GENERAL ADMINISTRATIVE AND ORGANIZATIONAL ACTIVITIES
2007
2009
2011
2012-current
2012-current
2013
2013-current
2013-current
2013-current
2013-current
2013-current
2014-current
Member of the Organizing Committee of the V Meeting of the Institute of Neuroscience
CNR, June 3-5, Cagliari, Italy.
Member of the Organizing Committee of the Settimana Mondiale del Cervello (March 1622), Promoter of a Cineforum and Speaker at the Meeting: “Conosci il tuo cervello: le
Neuroscienze si aprono alle scuole”.
Member of the Organizing Committee of the National Meeting “Cannabinoids: from biology
to clinic”, Sept 29-30, Cagliari, Italy.
Organizer of the International Olympic Games of Neuroscience for the Sardinia Region.
Council Member, International Meeting of the Mediterranean Neuroscience Society (MNS).
Member of the Organizing Committee of the XI Meeting of the Institute of Neuroscience
CNR, Pula (Italy).
Council Member, Italian Society of Neuroscience (SINS).
Member of the Working Group on Pathological Dependences, Italian Society of
Pharmacology (SIF).
Member of the Working Group on Neuropsychopharmacology, Italian Society of
Pharmacology (SIF).
Member of the European Lab Network Stud@tNet (www.studatnet.org).
President of the Organizer Committee for the 5th International Meeting of the Mediterranean
Neuroscience Society (MNS), to be held in June 2015 in Pula (Italy).
Member of the Organizer Committee for the XVI National Meeting of the Italian Society of
Neuroscience (SINS), to be held in 2015 in Cagliari (Italy).
SCIENTIFIC & EDITORIAL ACTIVITIES
Author of 43 Research Articles, 19 Reviews, 2 commentaries and 1 perspective article (all peer-reviewed).
Author of 14 scientific articles for general audience, 4 chapters for National books (in Italian), 5 chapters for
International books (Springer, Elsevier, Nova Publisher) and 1 monograph (in press).
Referee for 23 International Journals and ANR Expert Evaluator.
Co-Editor of the book “Cannabinoids and Modulation of Emotion, Memory, and Motivation”, Springer (in
press).
Editor of the book “Cannabinoids in Neurological and Mental Disease”, Elsevier (in press).
RESEARCH INTERESTS
Neuropsychopharmacology; Behavioral Pharmacology; Neurobiology of natural and drug reward;
Gender/sex differences; Drug and food addiction; Pathological Dependences; Psychiatric disorders and
Comorbity; New designer and Internet drugs.
Last 5-years PUBLICATIONS (2010-2014)
Devoto P*, Fattore L*, Antinori S, Saba P, Frau R, Fratta W, Gessa GL (2014) Elevated dopamine in the
medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation. Addict Biol 2014 Aug
19. doi: 10.1111/adb.12178. *equal contribution.
Serra V, Fattore L, Scherma M, Collu R, Spano MS, Fratta W, Fadda P (2014) Behavioural and
neurochemical assessment of salvinorin A abuse potential in the rat. Psychopharmacology 2014 Jun 13
[Epub ahead of print]
Fattore L, Melis M, Fadda P, Fratta W (2014) Sex differences in addictive disorders. Front Neuroendocrinol
35, 272-84.
Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, Dusek L, Fadda P, Micale V,
Sulcova A, Fratta W, Fattore L (2014) Enhanced self-administration of the CB1 receptor agonist
WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic
underlying mechanisms. Front Pharmacol 5, 44.
Morel C*, Fattore L*, Pons S, Marti F, De Biasi M, Lathrop M, Fratta W, Maskos U, Faure P (2014)
Nicotine consumption is regulated by a human polymorphism expressed in the dopaminergic system. Mol
Psychiatry 19, 930-6. *equal contribution.
Castelli MP, Fadda P, Casu A, Spano MS, Casti a, Fratta W, Fattore L (2014) Male and Female Rats Differ
in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug
Addiction: Effect of Ovarian Hormones Curr Pharm Design 20, 2100-13.
Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P (2014) The role of the endocannabinoid system in
eating disorders: neurochemical and behavioural preclinical evidence. Curr Pharm Design 20, 2089-99.
Castelli MP, Madeddu C, Casti A, Casu A, Casti P, Scherma M, Fattore L, Fadda P, Ennas MG (2014) ∆9tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. PLoS One 9, e98079.
Melis M, De Felice M, Lecca S, Fattore L, Pistis M (2013) Sex-specific tonic 2-arachidonoylglycerol
signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Front Integr Neurosci 7, 93.
Fratta W, Fattore L (2013) Molecular mechanisms of cannabinoid addiction. Curr Opin Neurobiol, 23, 48792.
Melis M, Scheggi S, Frau R, Carta G, Fattore L, Lecca S, Luchicchi A, Cadeddu F, Fadda P, Fratta W,
Schilstrom B, Banni S, De Montis MG, Pistis P (2013) PPARalpha regulate cholinergic-driven activity of
midbrain dopamine neurons via a novel negative feedback mechanism. J Neurosci 33, 6203-11.
Spano MS, Fattore L, Cadeddu F , Fratta W, Fadda P (2013) Chronic cannabinoid exposure reduces
phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology 225, 53142.
Scherma M, Fattore L, Satta V, Businco F, Pigliacampo B, Goldberg S, Dessy C, Fratta W, Fadda P (2013)
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female
rats. Br J Pharmacol 169, 820-33.
Fattore L (2013) Considering gender in cannabinoid research: a step toward personalized treatment of
marijuana addicts. Drug Test Anal 5, 57-61.
Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: A
review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol
Psychiatry 39, 234-43.
Davis C, Fattore L, Kaplan AS, Carter JC, Levitan RD, Kennedy JL (2012) The suppression of appetite and
food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults.
Int J Neuropsychopharmacol 15, 181-187.
Akirav I, Fattore L (2011) Cannabinoid CB1 and Dopamine D1 Receptors Partnership in the Modulation of
Emotional Neural Processing. Front Behav Neurosci 5, 67.
Fattore L, Fratta W (2011) Beyond THC: the new generation of cannabinoid designer drugs. Front Behav
Neurosci 5, 60.
Fattore L, Spano MS, Melis V, Fadda P, Fratta W (2011) Differential effect of opioid and cannabinoid
receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin abstinent rats. Br J
Pharmacol 163, 1550-62.
Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M (2010)
Peroxisome Proliferator-Activated Receptors-Alpha Modulate Dopamine Cell Activity Through Nicotinic
Receptors. Biol Psychiatry 68, 256-64.
Fattore L, Melis M, Fadda P, Pistis M, Fratta W (2010) The endocannabinoid system and rewarding
behaviours. Exp Neurol 224, 23-36.
Spano MS, Fadda P, Frau R, Fattore L, Fratta W (2010) Cannabinoid self-administration attenuates PCPinduced schizophrenia-like symptoms in adult rats. Eur Neuropsychopharmacol 20, 25-36.
Fattore L, Spano MS, Altea S, Fadda P, Fratta W (2010) Drug- and cue-induced reinstatement of
cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol 160,
724-35.
Fattore L, Fratta W (2010) How important are sex differences in cannabinoid action? Br J Pharmacol 160,
544-8.
Spano MS, Fadda P, Fratta W, Fattore L (2010) Cannabinoid-opioid interactions in drug discrimination and
self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Curr Drugs
Target 11, 450-61.
H-index: 29 (ISI).
Sum of Times Cited without self-citations: 3335 (ISI).